Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Ovarian Neoplasms 12Small Cell Lung Carcinoma 11Fallopian Tube Neoplasms 9Neuroblastoma 6Neoplasm Metastasis 3Lung Neoplasms 3Ganglioneuroblastoma 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Sarcoma, Ewing 2Rhabdoid Tumor 2Recurrence 2Leukemia, Myeloid, Acute 2Glioma 2Central Nervous System Neoplasms 2Wilms Tumor 1Thrombocythemia, Essential 1SCLC 1Primary Myelofibrosis 1Polycythemia Vera 1Pleuropulmonary blastoma 1Peritoneal Neoplasms 1Pediatric Brain Tumor 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

pembrolizumab 36Bevacizumab 25Cyclophosphamide 22Blood Specimen Collection 18Nivolumab 17Carboplatin 15Standard of Care 14Paclitaxel 14atezolizumab 13Gemcitabine 13Exercise 13Pemetrexed 11Fluorouracil 11Doxorubicin 11Cisplatin 11Cetuximab 10Radiotherapy 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Docetaxel 9durvalumab 8abemaciclib 8Temozolomide 8Surveys and Questionnaires 8Rituximab 8Prednisone 8Biopsy 8130-nm albumin-bound paclitaxel 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Topotecan × 90 days × Clear all
NCT02354547 2026-05-08

A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors

SynerGene Therapeutics, Inc.

Phase 1 Suspended
18 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡